Headquarters
9168 WOODEN RD, RALEIGH, NC 27617-8203, US
RALEIGH, NC, US
FLAG THERAPEUTICS, INC
From the company
FLAG Therapeutics, Inc. is a near-term clinical stage company headquartered in Raleigh, North Carolina, focused on developing new small molecule therapeutics for difficult-to-treat cancers. Its lead candidate, FLAG-003, targets diffuse intrinsic pontine glioma (DIPG) and glioblastoma multiforme (GBM) and is projected to enter Phase 1/2 clinical development in early 2026 in children with DIPG. The company leverages three proprietary drug discovery platforms and holds an exclusive worldwide licensing agreement with Duquesne University.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.